Esperion Therapeutics, Inc.

MI · United States · Reporting entity ID 100000771817

Total reported 2019–2025

$29.4M

#244 of 2,960 reporting companies — 0% of all reported industry payments

$13.2M in general payments across 197,050 records, plus $16.2M in research funding across 24,298 records.

How it breaks down

General payments $13,228,746

Research funding $16,207,000

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.